F19.288
Other psychoactive substance dependence with other psychoactive substance-induced disorder
Clinical Classification Guidelines
Inclusion Terms
- Other (or unknown) substance use disorder, moderate, with other (or unknown) substance induced mild neurocognitive disorder
- Other (or unknown) substance use disorder, severe, with other (or unknown) substance induced mild neurocognitive disorder
- Other (or unknown) substance use disorder, moderate, with other (or unknown) substance induced obsessive compulsive or related disorder
- Other (or unknown) substance use disorder, severe, with other (or unknown) substance induced obsessive-compulsive or related disorder
Medical Intelligence & Overview
ICD-10 code F19.288 refers to a complex condition involving dependence on psychoactive substances, coupled with additional mental health issues caused by these substances. This diagnosis indicates that an individual is dependent on certain substances and experiences related mental health disorders induced by their use. These conditions can significantly impact daily functioning and require comprehensive management.
Causes & Symptoms
Clinical Causes: Repeated use of psychoactive substances such as cannabis, opioids, stimulants, sedatives, or hallucinogens. Chronic exposure leading to physiological dependence, where the body adapts to the substance's presence. Genetic predisposition influencing vulnerability to addiction and related mental health issues. Environmental factors like stress, peer pressure, or availability of substances. Underlying mental health conditions that may contribute to substance use as a coping mechanism.
Key Symptoms: Craving or strong desire to use the substance. Increased tolerance, requiring larger amounts for the same effect. Withdrawal symptoms upon reducing or stopping use, such as sweating, nausea, anxiety, or tremors. Neglect of responsibilities at work, school, or home. Social withdrawal and loss of interest in previously enjoyed activities. Impaired ability to function in daily life due to substance effects. Presence of mental health symptoms such as obsessive-compulsive behaviors or mild cognitive impairment influenced by the substance use. Mood swings, irritability, or anxiety related to substance use or withdrawal.
Diagnostic & Treatment
Diagnosis Path: Diagnosis of this condition involves a detailed assessment by healthcare professionals, including a patient's medical and substance use history, physical examination, and psychological evaluation. Specific criteria from diagnostic manuals are used to determine dependence levels and whether substance-induced mental health disorders are present. Sometimes, additional tests or screening tools are employed to support the diagnosis.
Treatment Protocols: Detoxification and medical management for withdrawal symptoms when necessary. Psychotherapy, such as cognitive-behavioral therapy (CBT), to address dependency and underlying mental health issues. Medication-assisted treatment (MAT) in some cases to reduce cravings or manage withdrawal symptoms. Support groups and counseling to promote sustained recovery. Monitoring and management of co-occurring mental health disorders, like obsessive-compulsive behaviors or cognitive impairments. Lifestyle modifications to support recovery, including healthy routines and avoiding triggers.
Clinical Advice & FAQs
Billing Guidance
Is F19.288 a billable ICD-10 code?
Yes, F19.288 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F19.288?
Clinical documentation must specify the nature of Other psychoactive substance dependence with other psychoactive substance-induced disorder and any associated comorbidities for accurate reporting.
Cite this Clinical Reference